Clinical Trial Update: Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating once-daily intrapleural enzyme therapy for complicated parapneumonic effusion or empyema; currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Pleural Effusion
• Empyema
• Pleural Infection

Drugs mentioned

• Intrapleural enzyme therapy

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pleural Infection Bacterial, Pleural Infections | Phase 4 | Status: NOT_YET_RECRUITING